CarrièresEspace presseCOVID-19
  1. Home
  2. Imagerie Médicale
  3. Molecular Imaging
  4. Molecular Imaging Clinical Corner
  5. Clinical White Papers

Clinical White Papers

Discover the value of PET/CT and SPECT/CT through an assortment of clinical white papers on the role molecular imaging has in various clinical specialties, diseases, and cutting-edge technologies.

IQ•SPECT: a technical and clinical overview

 17.02.23
IQ•SPECT™ delivers fast myocardial perfusion imaging (MPI) with similar diagnostic confidence to low-energy high-resolution (LEHR), but with the advantage of high acquisition speed as well as the possibility of integrated diagnostic CT-based attenuation correction. This white paper briefly explains the technical aspects of IQ•SPECT and demonstrates normal patterns and variations, as well as shows a series of clinical examples of ischemia and infarction to familiarize nuclear cardiologists with IQ•SPECT.
White paper
xspect quant teaser

By Partha Ghosh, MD, Siemens Healthineers, Hoffman Estates, Illinois, USA

Clinical impact of absolute SPECT/CT quantification in theranostics and dosimetry

 17.02.23

Major advances in SPECT/CT technology have enabled absolute quantification to be accurate and reproducible. Download the white paper and explore the clinical impact of SPECT/CT quantification in theranostics and dosimetry.

White paper

By Vijay Shah, Ph.D., Siemens Healthineers

Automatic landmarking and parsing of human anatomy (ALPHA) for innovative and smart MI applications

 22.10.21
ALPHA technology reliably provides anatomical context and is used to enrich applications on the AIDAN platform and syngo©.via reading solutions.
White paper
syngo.via striatal analysis neurology white paper

By Rachid Fahmi, PhD and Guenther Platsch, MD, Siemens Healthineers

Striatal analysis in syngo.via MI Neurology

 06.10.21
Striatal analysis of FDOPA[a] and 123I-FP-CIT[a] images within syngo.via MI Neurology provides a tool for accurate visual interpretation of striatal uptake. Discover how striatal analysis supports VOI-based semi-quantitative analysis and comparison of a subject data to a database of normal reference values for a more objective evaluation of striatal uptake.
White paper
By Rachid Fahmi, PhD and Guenther Platsch, MD

syngo.via Database Comparison in MI Neurology

 23.07.21
Database Comparison enables a user to compare a PET or SPECT brain scan of a patient to a database of brain images of the same radiotracer composed of scans from confirmed normal individuals. Learn how Database Comparison supports such analysis for a variety of tracers, providing robust computational algorithms to automate necessary preparation of images.
White paper
syngo.via Lesion Scout with Auto ID Oncology

By Carl von Gall, MD, Vijay Shah, PhD, and Ludovic Sibille, MSc, Siemens Healthineers 

Lesion Scout with Auto ID in syngo.via MM Oncology

 01.02.21
Lesion Scout with Auto ID[a] is a tool in syngo.via VB50 MM Oncology using a state-of-the-art artificial intelligence algorithm designed to differentiate between physiological and non-physiological uptake. Discover how Lesion Scout with Auto ID supports physicians in calculating whole-body tumor burden and subsequently, MTV and TLG for 18F FDG PET/CT scans.
White paper
The value of PET/CT for melanoma

By Munir Ghesani, MD, FACNM, FACR, New York, NY, USA.

The value of PET/CT for melanoma

 04.04.19

PET/CT plays an increasingly important role in the appropriate clinical setting in both initial and subsequent treatment strategies in melanoma management. Read the white paper to discover the value PET/CT imaging can have for melanoma.

White paper
xSPECT Bone: a clinical overview

By Partha Ghosh, MD, Siemens Healthineers

xSPECT Bone: a clinical overview

 02.05.18

Skeletal scintigraphy has been a mainstay of nuclear medicine for decades. Take a closer look at clinical examples that illustrate the image quality levels in bone scintigraphy made possible using xSPECT Bone™ technology in this SPECT/CT clinical white paper.

White paper
Accurate, reproducible, and standardized quantification

By A. Hans Vija, PhD; Carl von Gall, MD; and Partha Ghosh, MD, Siemens Healthineers

Accurate, reproducible, and standardized quantification

 03.01.18

The introduction of xSPECT Quant™ for absolute quantification of 177Lu, 111In, and 123I is a major step toward implementation and expansion of standardized evidence-based medicine in the realm of radionuclide imaging. Download the white paper to learn more about Siemens Healthineers’ xSPECT Quant technology.

White paper
Characteristics of the xSPECT reconstruction method

By A. Hans Vija, PhD, Siemens Healthineers

Characteristics of the xSPECT reconstruction method

 30.09.17

In 2013, Siemens introduced xSPECT™, which represents a more complete integration of SPECT and CT data. Download the white paper to understand the fundamentals of xSPECT reconstruction for SPECT/CT and its advantages over traditional approaches.

White paper
Transitioning from mobile to fixed PET/CT services

By Jackson Kiser, MD, Molecular Imaging and Therapy Consultants of Virginia

Transitioning from mobile to fixed PET/CT services

 21.04.16

Discover how transitioning from a mobile PET scanner—an ideal way to introduce technology to facilities interested in exploring the potential for PET imaging— to a fixed scanner can benefit in a hospital setting.

White paper
Current role of PET/CT in evaluation of lung cancer

By Partha Ghosh, MD, Siemens Healthineers; and Dimitre Hristov, PhD, Department of Radiation Oncology, Stanford University

Current role of PET/CT in evaluation of lung cancer

 02.10.15

Learn how PET/CT provides metabolic and morphological information, which has a major impact on the evaluation and therapy planning of primary and recurrent lung tumors.

White paper
FDG PET/CT and breast cancer

By Kristin Schmiedehausen, MD

FDG PET/CT and breast cancer

 02.01.15

PET/CT plays an increasing role in breast cancer staging, treatment, and follow-up. Discover how new technical developments in PET scanner technologies might additional contribute to strengthening and expanding the role of clinical PET/CT in breast cancer care.

White paper
FDG PET/CT and cervical cancer

By Kristin Schmiedehausen, MD

FDG PET/CT and cervical cancer

 02.01.15

PET/CT is a powerful modality used to assess cervical cancer, particularly in tumors of stage IB and beyond. As the topic of cervical cancer and PET/CT has been increasing in interest in the last years, stay informed on the status of the disease, guidelines, and reimbursement opportunities by reading the following white paper.

White paper
The PET/CT imaging center as service provider to their clinical partners

By Kristin Schmiedehausen, MD

The PET/CT imaging center as service provider to their clinical partners

 02.01.15

Uncover how to ensure optimal patient management and learn how the relationship between the imaging and referring physician can help to ensure optimal patient management and benefit patients by having a more personal interaction before and after a PET/CT exam.

White paper